Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose methadone as adjunct to other opioids for refractory cancer pain
ChiCTR2500112381Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methadone in pain and cancer pain (2 arms), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Primary endpoint: Pain response rate. Started Nov 2025; status: recruiting.
02
Drugs
methadone
03
Conditions
paincancer pain
Beyond the preview
Go deeper on ChiCTR2500112381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112381.